170 related articles for article (PubMed ID: 31835761)
1. A Humanized Bone Niche Model Reveals Bone Tissue Preservation Upon Targeting Mitochondrial Complex I in Pseudo-Orthotopic Osteosarcoma.
Kurelac I; Abarrategi A; Ragazzi M; Iommarini L; Umesh Ganesh N; Snoeks T; Bonnet D; Porcelli AM; Malanchi I; Gasparre G
J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31835761
[TBL] [Abstract][Full Text] [Related]
2. Humanization of bone and bone marrow in an orthotopic site reveals new potential therapeutic targets in osteosarcoma.
Wagner F; Holzapfel BM; McGovern JA; Shafiee A; Baldwin JG; Martine LC; Lahr CA; Wunner FM; Friis T; Bas O; Boxberg M; Prodinger PM; Shokoohmand A; Moi D; Mazzieri R; Loessner D; Hutmacher DW
Biomaterials; 2018 Jul; 171():230-246. PubMed ID: 29705656
[TBL] [Abstract][Full Text] [Related]
3. Acidity-Triggered Transformable Polypeptide Self-Assembly to Initiate Tumor-Specific Biomineralization.
Liu Y; Jiang Z; Tong S; Sun Y; Zhang Y; Zhang J; Zhao D; Su Y; Ding J; Chen X
Adv Mater; 2023 Apr; 35(15):e2203291. PubMed ID: 36326058
[TBL] [Abstract][Full Text] [Related]
4. Interstitial fluid pressure in human osteosarcoma xenografts: significance of implantation site and the response to intratumoral injection of hyaluronidase.
Brekken C; Bruland ØS; de Lange Davies C
Anticancer Res; 2000; 20(5B):3503-12. PubMed ID: 11131654
[TBL] [Abstract][Full Text] [Related]
5. A humanized orthotopic mouse model for preclinical evaluation of immunotherapy in Ewing sarcoma.
Luo W; Hoang H; Liao Y; Pan J; Ayello J; Cairo MS
Front Immunol; 2023; 14():1277987. PubMed ID: 37868989
[TBL] [Abstract][Full Text] [Related]
6. Single-cell transcriptomics reveals the regulative roles of cancer associated fibroblasts in tumor immune microenvironment of recurrent osteosarcoma.
Huang X; Wang L; Guo H; Zhang W; Shao Z
Theranostics; 2022; 12(13):5877-5887. PubMed ID: 35966586
[No Abstract] [Full Text] [Related]
7. A humanized bone microenvironment uncovers HIF2 alpha as a latent marker for osteosarcoma.
Wagner F; Holzapfel BM; Martine LC; McGovern J; Lahr CA; Boxberg M; Prodinger PM; Grässel S; Loessner D; Hutmacher DW
Acta Biomater; 2019 Apr; 89():372-381. PubMed ID: 30836200
[TBL] [Abstract][Full Text] [Related]
8. Creating
Chow T; Wutami I; Lucarelli E; Choong PF; Duchi S; Di Bella C
Tissue Eng Part B Rev; 2021 Oct; 27(5):514-529. PubMed ID: 33138724
[TBL] [Abstract][Full Text] [Related]
9. Macrophages in Osteosarcoma Immune Microenvironment: Implications for Immunotherapy.
Luo ZW; Liu PP; Wang ZX; Chen CY; Xie H
Front Oncol; 2020; 10():586580. PubMed ID: 33363016
[TBL] [Abstract][Full Text] [Related]
10. Sulfatinib, a novel multi-targeted tyrosine kinase inhibitor of FGFR1, CSF1R, and VEGFR1-3, suppresses osteosarcoma proliferation and invasion
Liao S; Li J; Gao S; Han Y; Han X; Wu Y; Bi J; Xu M; Bi W
Front Oncol; 2023; 13():1158857. PubMed ID: 37361567
[TBL] [Abstract][Full Text] [Related]
11. Development of a Bioluminescent Human Osteosarcoma Model in Humanized NSG Mice: A Pilot Study.
Ko Y; Jeong YH; Seo JH; Lee JA
In Vivo; 2021; 35(4):2151-2157. PubMed ID: 34182491
[TBL] [Abstract][Full Text] [Related]
12. A tumor microenvironment-based prognostic index for osteosarcoma.
Wu C; Gong S; Duan Y; Deng C; Kallendrusch S; Berninghausen L; Osterhoff G; Schopow N
J Biomed Sci; 2023 Apr; 30(1):23. PubMed ID: 37055822
[TBL] [Abstract][Full Text] [Related]
13. Infiltration of LPAR5
He Y; Zhou H; Huang X; Qu Y; Wang Y; Pei W; Zhang R; Chen S; You H
Front Immunol; 2022; 13():909932. PubMed ID: 36591220
[TBL] [Abstract][Full Text] [Related]
14. A 3D-printed biomaterials-based platform to advance established therapy avenues against primary bone cancers.
Lahr CA; Landgraf M; Sanchez-Herrero A; Dang HP; Wagner F; Bas O; Bray LJ; Tran P; Holzapfel BM; Shafiee A; McGovern JA; Hutmacher DW
Acta Biomater; 2020 Dec; 118():69-82. PubMed ID: 33039595
[TBL] [Abstract][Full Text] [Related]
15. A humanized orthotopic tumor microenvironment alters the bone metastatic tropism of prostate cancer cells.
McGovern JA; Bock N; Shafiee A; Martine LC; Wagner F; Baldwin JG; Landgraf M; Lahr CA; Meinert C; Williams ED; Pollock PM; Denham J; Russell PJ; Risbridger GP; Clements JA; Loessner D; Holzapfel BM; Hutmacher DW
Commun Biol; 2021 Aug; 4(1):1014. PubMed ID: 34462519
[TBL] [Abstract][Full Text] [Related]
16. Is Use of BMP-2 Associated with Tumor Growth and Osteoblastic Differentiation in Murine Models of Osteosarcoma?
Kendal JK; Singla A; Affan A; Hildebrand K; Al-Ani A; Ungrin M; Mahoney DJ; Itani D; Jirik FR; Monument MJ
Clin Orthop Relat Res; 2020 Dec; 478(12):2921-2933. PubMed ID: 33275394
[TBL] [Abstract][Full Text] [Related]
17. Integrated transcriptomic analysis systematically reveals the heterogeneity and molecular characterization of cancer-associated fibroblasts in osteosarcoma.
Liu Y; Han X; Han Y; Bi J; Wu Y; Xiang D; Zhang Y; Bi W; Xu M; Li J
Gene; 2024 May; 907():148286. PubMed ID: 38367852
[TBL] [Abstract][Full Text] [Related]
18. Osteomimetic matrix components alter cell migration and drug response in a 3D tumour-engineered osteosarcoma model.
Pavlou M; Shah M; Gikas P; Briggs T; Roberts SJ; Cheema U
Acta Biomater; 2019 Sep; 96():247-257. PubMed ID: 31302294
[TBL] [Abstract][Full Text] [Related]
19. Development of a preclinical orthotopic xenograft model of ewing sarcoma and other human malignant bone disease using advanced in vivo imaging.
Vormoor B; Knizia HK; Batey MA; Almeida GS; Wilson I; Dildey P; Sharma A; Blair H; Hide IG; Heidenreich O; Vormoor J; Maxwell RJ; Bacon CM
PLoS One; 2014; 9(1):e85128. PubMed ID: 24409320
[TBL] [Abstract][Full Text] [Related]
20. Role of microRNAs in the crosstalk between osteosarcoma cells and the tumour microenvironment.
Lei Y; Junxin C; Yongcan H; Xiaoguang L; Binsheng Y
J Bone Oncol; 2020 Dec; 25():100322. PubMed ID: 33083216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
